Intrahepatic Cholestasis of Pregnancy and Associated Adverse Maternal and Fetal Outcomes: A Retrospective Case-Control Study
Table 1
Characteristics of ICP and control groups.
Characteristics
ICP
Control
value
114
570
Age (years)
30.00 (28.00, 34.00)
30.00 (28.00, 33.00)
1.00
Pregestational BMI (kg/m2)
19.77 (18.65, 20.96)
19.69 (18.59, 20.96)
0.83
SBP (mmHg)
107.00 (101.00, 113.00)
107.00 (100.00, 114.00)
0.81
DBP (mmHg)
66.00 (60.00, 72.00)
66.00 (60.00, 72.00)
0.91
0hBG (mmol/l)
4.33 (4.13, 4.62)
4.40 (4.18, 461)
0.39
1hBG (mmol/l)
7.69 (6.70, 9.02)
7.65 (6.52, 8.86)
0.39
2hBG (mmol/l)
6.57 (5.77, 7.49)
6.61 (5.87, 7.76)
0.60
Total bile acid (μmol/l)
20.23 (14.63, 28.32)
2.20 (1.63, 3.04)
Gestational age at delivery (weeks)
39.00 (38.00, 39.57)
39.71 (39.14, 40.43)
Birth weight (g)
Data are presented as or as medians with the interquartile ranges. ICP—patients with . ICP: intrahepatic cholestasis of pregnancy; SBP: systolic blood pressure; DBP: diastolic blood pressure; OGTT: oral glucose tolerance test; 0hBG: 0 h postprandial blood glucose; 1hBG: 1 h postprandial blood glucose; 2hBG: 2 h postprandial blood glucose.
